Pulling SEC filings + quote and writing the call…
ASND
Ascendis Pharma A/S
Next earnings Aug 5, 2026 (after close) · consensus $1.43 EPS, $339M rev
$232.11
▲ +0.55%$230.83▲ +29.89%
over 1Y
L $163.32EODHDH $249.84
Today+0.6%
1W+7.1%
1M-3.0%
3M+3.1%
YTD+8.2%
1Y+29.9%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 26 analysts
Strong Buy
Mixed signals in the latest filings.
Ascendis Pharma A/S shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001612042, latest 6-K filed 2026-06-17) · EODHD · as of 6/22/2026, 2:24:57 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.